Skip to content

Anika Therapeutics, Inc.: 10-K filed 2012-03-13

What Anika Therapeutics, Inc. reported in its annual report filed 2012-03-13 (fiscal FY 2011): 39 published measures, 102 facts as tagged in accession 0001157523-12-001365.

This filing

Form
10-K (annual report)
Filed
2012-03-13
Fiscal period
fiscal FY 2011
Accession
0001157523-12-001365 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Anika Therapeutics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-12-31132,844,434USD
At 2010-12-31128,936,868USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-12-3194,762,778USD
At 2010-12-3185,190,146USD
At 2009-12-3182,143,502USD
At 2008-12-3160,756,984USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-12-3135,777,222USD
At 2010-12-3128,201,932USD
At 2009-12-3124,426,990USD
At 2008-12-3143,193,655USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-01-01 to 2011-12-318,466,680USD365
2010-01-01 to 2010-12-314,315,995USD365
2009-01-01 to 2009-12-313,687,567USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-12-3110,173,134USD365
2010-01-01 to 2010-12-317,853,461USD365
2009-01-01 to 2009-12-313,094,705USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-01-01 to 2011-12-311,400,348USD365
2010-01-01 to 2010-12-312,784,977USD365
2009-01-01 to 2009-12-313,962,232USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-1,165,340USD365
2010-01-01 to 2010-12-31-1,337,320USD365
2009-01-01 to 2009-12-31-1,643,501USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-1,400,348USD365
2010-01-01 to 2010-12-31-2,679,677USD365
2009-01-01 to 2009-12-31-20,217,869USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-12-3134,252,221USD
At 2010-12-3125,785,541USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2011-01-01 to 2011-12-3113,064,051shares365
2010-01-01 to 2010-12-3112,624,495shares365
2009-01-01 to 2009-12-3111,386,989shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2011-01-01 to 2011-12-3113,747,813shares365
2010-01-01 to 2010-12-3113,646,533shares365
2009-01-01 to 2009-12-3111,562,304shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2011-01-01 to 2011-12-310.65USD/shares365
2010-01-01 to 2010-12-310.34USD/shares365
2009-01-01 to 2009-12-310.32USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2011-01-01 to 2011-12-310.62USD/shares365
2010-01-01 to 2010-12-310.32USD/shares365
2009-01-01 to 2009-12-310.32USD/shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2011-01-01 to 2011-12-315,318,334USD365
2010-01-01 to 2010-12-313,027,071USD365
2009-01-01 to 2009-12-311,824,692USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-12-3136,469,878USD
At 2010-12-3136,981,394USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-01-01 to 2011-12-311,190,697USD365
2010-01-01 to 2010-12-311,102,617USD365
2009-01-01 to 2009-12-31958,025USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-12-3113,967,402USD365
2010-01-01 to 2010-12-317,537,686USD365
2009-01-01 to 2009-12-315,586,739USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-12-3164,137,544USD
At 2010-12-3156,322,336USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-12-3114,538,423USD
At 2010-12-3119,369,940USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2011-12-314,299,680USD
At 2010-12-319,694,355USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2011-12-318,883,407USD
At 2010-12-319,091,960USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2011-12-3117,307,786USD
At 2010-12-3114,819,868USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2011-12-317,302,483USD
At 2010-12-318,949,745USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2011-01-01 to 2011-12-3117,858,558USD365
2010-01-01 to 2010-12-3117,317,671USD365
2009-01-01 to 2009-12-3110,545,351USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-01-01 to 2011-12-316,168,937USD365
2010-01-01 to 2010-12-316,874,633USD365
2009-01-01 to 2009-12-318,181,532USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-12-3113,630,607shares
At 2010-12-3113,482,384shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-12-3163,441,433USD
At 2010-12-3161,817,558USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2011-12-3150,850,630USD
At 2010-12-3149,696,989USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2011-12-3114,380,752USD
At 2010-12-3112,715,595USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2011-12-3123,148,563USD
At 2010-12-3125,764,185USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2011-12-311,548,652USD
At 2010-12-311,560,205USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2011-12-315,321,594USD
At 2010-12-315,375,585USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2011-12-311,831,127USD
At 2010-12-312,360,182USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2011-01-01 to 2011-12-317,947,275USD365
2010-01-01 to 2010-12-311,768,219USD365
2009-01-01 to 2009-12-313,687,567USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2011-01-01 to 2011-12-314,002,391USD365
2010-01-01 to 2010-12-313,320,352USD365
2009-01-01 to 2009-12-311,293,468USD365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2011-01-01 to 2011-12-311,989,708USD365
2010-01-01 to 2010-12-311,953,946USD365
2009-01-01 to 2009-12-311,735,947USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-12-312,998,037USD365
2010-01-01 to 2010-12-313,716,478USD365
2009-01-01 to 2009-12-311,697,673USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-224,714USD365
2010-01-01 to 2010-12-311,220,359USD365
2009-01-01 to 2009-12-311,871,545USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-6,594,292USD365
2010-01-01 to 2010-12-315,784,731USD365
2009-01-01 to 2009-12-31141,083USD365

Inspect the source

Entity
Anika Therapeutics, Inc. / CIK 0000898437
Captured
2026-09-20T05:04:56.960Z
SEC response SHA-256
f1da3290842851cfa646165073c3c5bf9c06212e35bc3d1892f2be77cae8b535

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000898437.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))